SS-OCT system is successful in evaluating macular choroidal thickness

Article

A study featured in Investigative Ophthalmology and Visual Science has demonstrated the accuracy of the swep-source optical coherence tomography (SS-OCT) system in evaluating choroidal thickness.

A study featured in Investigative Ophthalmology and Visual Science has demonstrated the accuracy of the swep-source optical coherence tomography (SS-OCT) system in evaluating choroidal thickness.

Dr Akitaka Tsujikawa et al., Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Sakyo-ku, Japan, studied the macular area of 31 eyes from 31 healthy partcipants. Scans were completed in 0.8 seconds with an SS-OCT prototype system. The system’s light source is a tunable laser operating at 100,00 Hz.

The choroidal thickness map of the macular area was obtained by manual segmentation and was assessed in 10 participants by two observers.

It was found that the system enabled the visualization of the fine structure of the choroid and the retina. The mean macular volume and choroidal thickness were 191.5 ± 74.2 μm and 5.411 ± 2.097 mm3, respectively.

The results also demonstrated the intraclass correlation coefficient in mean choroidal thickness was between 0.945 and 0.980 in each area, meaning the measurements recorded the two observers were significantly identical.

Macular choroidal thickness was strongly linked to axial length after adjustment for age and age after adjustment for axial length. The SS-OCT at 1 μm provides a significantly accurate method for the measurement of choroidal thickness.

Recent Videos
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
Brent Kramer, MD, of Vance Thompson Vision speaks at the 2024 AAO meeting
© 2025 MJH Life Sciences

All rights reserved.